LEAPT: lectin-directed enzyme-activated prodrug therapy.

LEAPT: lectin-directed enzyme-activated prodrug therapy.

Targeted drug delivery to selected sites allows reduced toxicity, enhanced efficiency and interchangeable target potential [Langer, R. (2001) Science 293, 58-59 and Molema, G. and Meijer, D. K. F., eds. (2001) Drug Targeting (Wiley-VCH, Weinheim, Germany)]. We describe a bipartite drug-delivery syst...

Full description

Bibliographic Details
Main Authors:	Robinson, M, Charlton, S, Garnier, P, Wang, X, Davis, S, Perkins, A, Frier, M, Duncan, R, Savage, T, Wyatt, D, Watson, SA, Davis, B
Format:	Journal article
Language:	English
Published:	2004

Similar Items

Lectin-directed enzyme activated prodrug therapy (LEAPT): Synthesis and evaluation of rhamnose-capped prodrugs.
by: Garnier, P, et al.
Published: (2010)

Virus-directed, Enzyme Prodrug Therapy with Nitroimidazole Reductase: A Phase I and Pharmacokinetic Study of its Prodrug, CB1954
by: Chung-Faye, G, et al.
Published: (2001)

Nitroreductase: a prodrug-activating enzyme for cancer gene therapy.
by: Searle, P, et al.
Published: (2004)

Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapy.
by: Palmer, D, et al.
Published: (2005)

The nitroreductase/CB1954 enzyme-prodrug system.
by: Green, N, et al.
Published: (2004)

Virus-directed enzyme prodrug therapy: intratumoral administration of a replication-deficient adenovirus encoding nitroreductase to patients with resectable liver cancer.
by: Palmer, D, et al.
Published: (2004)

Lectins: tools for the molecular understanding of the glycocode.
by: Ambrosi, M, et al.
Published: (2005)

The horseradish peroxidase/indole-3-acetic acid combination for enzyme prodrug therapy: RROM in vitro to in vivo.
by: Tupper, J, et al.
Published: (2002)

Responsive supramolecular prodrug nanoparticles for cancer therapy
by: Chen, Hongzhong
Published: (2017)

Quinone oxidoreductase-2-mediated prodrug cancer therapy.
by: Middleton, MR, et al.
Published: (2010)

Glycosyldiselenides as lectin ligands detectable by NMR in biofluids
by: Pérez-Victoria, I, et al.
Published: (2015)

Development of a novel enzyme/prodrug combination for gene therapy of cancer: horseradish peroxidase/indole-3-acetic acid.
by: Greco, O, et al.
Published: (2000)

Modular control of lectin function: redox-switchable agglutination.
by: McDonald, R, et al.
Published: (2004)

Emerging strategies in stimuli-responsive prodrug nanosystems for cancer therapy
by: Ding, Chendi, et al.
Published: (2023)

Selective thrombosis of tumor for enhanced hypoxia-activated prodrug therapy
by: Ma, Zhaoyu, et al.
Published: (2022)

Hypoxia-driven elimination of thiopurines from their nitrobenzyl prodrugs.
by: Thomson, P, et al.
Published: (2007)

Synthesis and biological properties of bioreductively targeted nitrothienyl prodrugs of combretastatin A-4.
by: Thomson, P, et al.
Published: (2006)

Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer.
by: Denmeade, SR, et al.
Published: (2003)

Colchicine Prodrugs and Codrugs: Chemistry and Bioactivities
by: Ghawanmeh, Abdullah A., et al.
Published: (2018)

On the design of a bacterial cell-based prodrug enzyme system for HER2 positive breast cancer:
by: Kuziez, A
Published: (2023)

Light-responsive prodrug-based supramolecular nanosystems for site-specific combination therapy of cancer
by: Phua, Fiona Soo Zeng, et al.
Published: (2020)

A semiconducting polymer nano-prodrug for hypoxia-activated synergetic photodynamic cancer therapy
by: Cui, Dong, et al.
Published: (2019)

Self-assembled oxaliplatin(IV) prodrug-porphyrin conjugate for combinational photodynamic therapy and chemotherapy
by: Lim, Wei Qi, et al.
Published: (2021)

Horseradish peroxidase-mediated gene therapy: choice of prodrugs in oxic and anoxic tumor conditions.
by: Greco, O, et al.
Published: (2001)

The lectin pathway of complement activation
by: Krarup, A
Published: (2007)

Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
by: Dhar, Shanta, et al.
Published: (2011)

Starvation, ferroptosis, and prodrug therapy synergistically enabled by a cytochrome c oxidase like nanozyme
by: Cao, Changyu, et al.
Published: (2022)

Cancer-targeted design of bioresponsive prodrug with enhanced cellular uptake to achieve precise cancer therapy
by: Liang, Yuanwei, et al.
Published: (2019)

Halogenated indole-3-acetic acids as oxidatively activated prodrugs with potential for targeted cancer therapy.
by: Rossiter, S, et al.
Published: (2002)

Mechanism of cell death induced by the novel enzyme-prodrug combination, nitroreductase/CB1954, and identification of synergism with 5-fluorouracil.
by: Palmer, D, et al.
Published: (2003)

Catalytic antibodies for amide cleavage and prodrug activation
by: Fleck, Roman (Roman W.), 1966-
Published: (2005)

The tuberculosis prodrug isoniazid bound to activating peroxidases.
by: Metcalfe, C, et al.
Published: (2008)

Pt(IV) anticancer prodrugs and liposomal encapsulation
by: Marsh, L
Published: (2022)

Sialic acid recognition by sialoadhesin and related lectins
by: Vinson, M, et al.
Published: (1997)

Lectin-like Transcript 1 in Germinal Centres
by: Llibre, A, et al.
Published: (2014)

Organization of the mouse macrophage C-type lectin (Mcl) gene and identification of a subgroup of related lectin molecules.
by: Balch, S, et al.
Published: (2002)

Clinical advances of hypoxia-activated prodrugs in combination with radiotherapy
by: Mistry, I, et al.
Published: (2017)

Glycosylation influences the lectin activities of the mannose receptor
by: Yunpeng, Y, et al.
Published: (2005)

Antibody-based imaging of bioreductive prodrug release in hypoxia
by: Tosun, C, et al.
Published: (2023)

Enzyme catalysis: sweet flexibility.
by: Davis, B
Published: (2010)